On the other hand, PGPIPN, a hexapeptide derivate from bovine β-casein residues 63–68, inhibited the proliferation of human ovarian cancer cells as well as the primary tumor growth via downregulation of BCL-2 signaling [50]. This evidence concerns the gene BCL2 and ovarian cancer.